Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

JUBILANT DRAXIMAGE INC

Subsidiary ofJUBILANT LIFE SCIENCES LIMITEDUEI: M3XTBYTERVN5CAGE: L02J7

JUBILANT DRAXIMAGE INC is a federal contractor, registered under UEI M3XTBYTERVN5 and CAGE code L02J7. It has been awarded $5,091,253 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Medicinal and Botanical Manufacturing, and Drugs and Druggists' Sundries Merchant Wholesalers. Top awarding agencies include Department Of Veterans Affairs, Department Of Health And Human Services, and Department Of Defense.

Contact Information

Registration and classification details

Websitewww.jubilantradiopharma.com

Address123 Main St, City, ST 12345

Registration

UEI Code

M3XTBYTERVN5

CAGE Code

L02J7

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325411Medicinal and Botanical Manufacturing

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Jubilant DraxImage Inc. specializes in the manufacturing and supply of radiopharmaceuticals, with deep expertise in the production of radioactive isotopes for diagnostic and therapeutic applications in nuclear medicine. The company’s technical capabilities center on GMP-compliant radiopharmaceutical...

Key Performance Metrics

Awards Count

27

All time

Active

1

Currently performing

Completed

26

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Veterans Affairs$5.0M98.6%Department Of Health And Human Services$41.6K0.8%Department Of Defense$30.7K0.6%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$4.9M97%325411 - Medicinal and Botanical Manufacturing$78.3K1.5%424210 - Drugs and Druggists' Sundries Merchant Wholesalers$45.4K0.9%

Others - Other NAICS codes (3 codes, <0.5% each)$26.9K0.5%

Awards by Agency Over Time

Awards by Place of Performance

Compete with JUBILANT DRAXIMAGE INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for JUBILANT DRAXIMAGE INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in JUBILANT DRAXIMAGE INC's top NAICS codes and agencies

PEO-M Undersea Test Shape and Cradle Assessment Event (AE)

Solicitation # PEO_M_Undersea_Test__Shape_and_Cradle_AE

Department Of Defense

POSTED

about 16 hours ago

DEADLINE

Area of Interest (AoI) – Metal Cleaning and Finishing Services

Solicitation # W911KF25SC002-AoI0016

The Army Contracting Command Anniston Army Depot is seeking innovative commercial solutions for depot-level metal cleaning, surface preparation, and finishing services for combat vehicle components. This requirement, issued under solicitation W911KF25SC002-AoI0016, encompasses chemical stripping, alkaline immersion cleaning, and abrasive media cleaning to remove paint, corrosion, scale, and carbon. The scope includes a wide array of plating and coating processes such as anodizing, chromate conversion, black oxide, electroless nickel, hard chrome, zinc, tin, copper, and phosphate. The government anticipates utilizing a Multiple Award Task Order Contract structure to ensure technical redundancy and coverage. Key performance requirements include a strict seven-working-day turnaround time and the contractor's responsibility for the secure pick-up and delivery of parts to and from the depot in Alabama. Offerors must demonstrate significant facility capabilities, including specific tank and oven dimensions, crane clearances, and the capacity to handle high-volume part streams of varying sizes. A rigorous quality assurance approach is mandatory, requiring the ability to perform various ASTM and MIL-SPEC tests, such as salt spray, adhesion, and hydrogen embrittlement, either in-house or through certified laboratories. Evaluation will be based on technical feasibility, the safety and efficiency of cleaning methods, innovation in eco-friendly processing, and the robustness of quality control systems. Additionally, the government will assess the offeror's track record with hazardous material management and compliance with environmental regulations. Interested parties must submit a written Solution Brief by October 28, 2026, including a Rough Order of Magnitude or unit pricing structure for evaluation.

Department Of Defense

POSTED

about 16 hours ago

DEADLINE

Pralidoxime Chloride/Methyl Sulfate ManufacturingThis subcontract involves the manufacture and supply of Pralidoxime chloride or methyl sulfate in solution or powder form for injection to support prime contractors on Department of National Defence projects. The required product must have a dosage strength of at least 200 mg per container and a minimum shelf-life of 36 months. The selected provider is responsible for conducting stability testing, providing quality assurance certification, and delivering complete treatment courses along with stability reports and product monographs. To be eligible, the manufacturer must hold a Health Canada Notice of Compliance under Division 8 or Division 11 authorization. This global procurement opportunity is managed by the Government of Canada and allows for performance across various international regions. Interested parties must submit their responses by November 10, 2026.

Department of National Defence

POSTED

about 23 hours ago

DEADLINE

SLS Printer Consumables and Maintenance KitsThis subcontract focuses on the provision of specialized consumables and wear-and-tear replacement parts to support prime contractors working on Department of National Defence projects for the Government of Canada. The scope of supply includes engineering-grade thermoplastic powders such as PA 11, PA 12, PP, and TPU, along with critical SLS hardware components including optical cassettes, recoater blades, infrared heaters, sealing foam gaskets, and build chambers. All bulk consumables and spare parts kits are to be delivered to CFB Petawawa. The opportunity was posted on October 20, 2026, with a response deadline of November 2, 2026, falling under NAICS code 325412.

Department of National Defence

POSTED

about 23 hours ago

DEADLINE

Solicitation # W6369-26-A033/B

The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.

Department of National Defence

POSTED

about 23 hours ago

DEADLINE

Supplier of Red Sealing Compound (NSN 8030015650423)This subcontract involves the supply of red sealing compound, identified by NSN 8030015650423, for prime contractors working under the Defense Logistics Agency. The material must be provided in 10.00 milliliter containers and strictly adhere to the DLA Master List of Technical and Quality Requirements RA001. The supplier is responsible for managing TYPE I (CODE H) shelf-life requirements and ensuring all packaging complies with MIL-STD-2073-1E and MIL-STD-129 standards. Additionally, the contractor must provide all necessary safety documentation, including SDS and HazCom labels in accordance with 29 C.F.R. 1910.1200. The performance of this contract is centered in FPO 09591-0100, with the primary objective being the delivery of packaged sealing compound and its associated safety certifications to the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyThis subcontract for Active Pharmaceutical Ingredient (API) Supply involves the synthesis, purification, and bulk delivery of pharmaceutical-grade Benzocaine and Menthol. The provider supports prime contractors fulfilling requirements for the Department of Defense Medical Supply Chain Pharm FSA, ensuring all raw chemical components meet strict USP and ISO manufacturing standards through the use of HPLC purity testing. The performance of this contract is centered at Fort Campbell, Kentucky, under NAICS code 325412. The solicitation was posted on October 19, 2026, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzocaine and Menthol Lozenge SupplyThis subcontract involves the manufacture and supply of finished Benzocaine and Menthol lozenges to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for producing and quality-testing pharmaceutical lozenges within FDA-compliant facilities adhering to Good Manufacturing Practice standards to ensure all delivered quantities meet strict government specifications. Administrative processes for this requirement are managed through the DLA Internet Bid Board System for quote submissions. The performance of the contract is centered at Fort Campbell, and the procurement falls under NAICS code 325412 for pharmaceutical preparation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the manufacture and supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets (400 MG). The contractor is responsible for providing the antibiotic tablets in 30-count bottles, ensuring all products are sourced or manufactured in accordance with Good Manufacturing Practices and FDA approval and registration requirements. Logistical compliance is critical, as the contract mandates adherence to RP001 DLA Packaging Requirements and the use of climate-controlled storage and transport to maintain product integrity. Performance will take place in FPO 09591, with the primary objective of supporting prime contractors on DLA supply contracts.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Activated Charcoal, SuspensionThis subcontract, issued by the Medical Supply Chain Pharm FSA under the Department of Defense, requires the provision of activated charcoal in suspension form, identified by NSN 6505012828880. The materials must be delivered to the USS Lewis B Puller ESB 3, with all shipments adhering to strict DLA packaging requirements and technical specifications. The contract falls under NAICS code 325412 and is intended for prime contractors supporting DLA supply operations. Resellers are specifically required to comply with the Non-Manufacturer Rule to ensure eligibility. The performance location is designated as FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical DetergentThis subcontract involves the supply of FDA-regulated 4% Chlorhexidine Gluconate surgical detergent for prime contractors supporting Department of Defense supply contracts. The provider is responsible for manufacturing or sourcing the chemical compound in strict accordance with NSN 6505-01-101-3759 specifications and DLA Packaging Requirements RP001. To maintain quality and regulatory compliance, the product must be produced in FDA-approved pharmaceutical manufacturing facilities. The contract mandates a total shelf life of 24 months, with a requirement that the detergent possesses at least 21 months of remaining shelf life at the time of delivery. Managed under the Medical Supply Chain Pharm FSA, the performance of this contract is centered in FPO 96660, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Omeprazole Extended-Release CapsulesThis subcontract involves the supply of eight bottles of pharmaceutical-grade Omeprazole Extended-Release Capsules to prime contractors supporting Department of Defense supply contracts at Fort Bliss, Texas. The capsules must strictly adhere to NSN 6505-01-314-2716 specifications and be handled through licensed pharmaceutical distribution facilities. To ensure compliance, the provider must maintain all necessary pharmaceutical supplier licenses and follow DLA packaging standards. The contract mandates the use of traceable shipping methods to guarantee a delivery timeline of 15 days. This procurement falls under NAICS code 424210 and is managed through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine and Epinephrine Injection to prime contractors supporting DLA Troop Support medical supply contracts. The provider must deliver end items compliant with NSN 6505-01-189-3973, utilizing pharmaceutical-grade materials and medical-grade packaging. To qualify, the supplier is required to hold all necessary pharmaceutical manufacturing licenses and maintain FDA approval for the specific drug formulation. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract specifies the delivery of injectable medication quantities as outlined in the award. The performance location is designated as FPO 09591, and the procurement falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet ManufacturingThis subcontract involves the manufacturing of Isoniazid 300 MG tablets for prime contractors supporting Department of Defense pharmaceutical supply contracts through the Medical Supply Chain Pharm FSA. The manufacturer is responsible for producing tablets that conform to United States Pharmacopeia standards, packaged in bottles of 100 units. To execute this contract, the provider must utilize pharmaceutical grade API, specialized tablet pressing equipment, and a USP-compliant quality control laboratory. Strict regulatory adherence is required, including the maintenance of active FDA registration and continuous USP compliance. The performance of this contract is centered in FPO 09591, with the primary objective of delivering finished pharmaceutical products that meet all specified government quality and safety benchmarks.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution SupplierThis subcontract involves the supply of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (0.05%, 15 ML) to support prime contractors under DLA Troop Support medical supply contracts. The selected provider is responsible for manufacturing or sourcing the pharmaceutical solution in accordance with USP standards, utilizing sterile ophthalmic bottling and packaging. All operations must comply with FDA approval and registration requirements for pharmaceutical manufacturing. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA. Physical deliveries of the ophthalmic solution are to be made to either the prime contractor or the Naval Med Readiness Logistics Command, with the place of performance located in Williamsburg, Virginia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Tolnaftate Powder, USP 1%, to prime contractors on DLA Troop Support medical supply contracts. The requirement is for 15 bottles of 45 GM powder, identified by NSN 6505014807897, which must strictly adhere to USP 1% standards and the DLA Master List of Technical and Quality Requirements. Eligible providers must possess the necessary pharmaceutical manufacturing and distribution licenses to fulfill the order. The performance of this contract is designated for FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DETERGENT, SURGICAL

Solicitation # SPE2DP-27-T-0122

Solicitation SPE2DP-27-T-0122 is a procurement request by the Defense Logistics Agency for surgical detergent containing 4% chlorhexidine gluconate, identified by NSN 6505-01-101-3759. The requirement is for one 8 oz bottle to be delivered FOB Destination to the USNS ABLE TAGOS 20. The item is FDA regulated and must have a total shelf life of 24 months, with at least 21 months remaining upon delivery to the government. The original required delivery date is October 21, 2026, with a delivery lead time of 20 days after award. The contract mandates strict adherence to Medical Marking Standard No. 1C and DLA packaging requirements RP001. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. Offerors must submit quotes via DIBBS by October 26, 2026, and provide a Safety Data Sheet meeting 29 CFR 1910.1200(g) prior to award. The procurement is subject to destination inspection under FAR 52.246-2 and incorporates the Buy American Act and HUBZone price evaluation preferences. Invoicing and receiving reports must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TETRAHYDROZOLINE HYDRO

Solicitation # SPE2DP-27-T-0130

Solicitation SPE2DP-27-T-0130 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (NSN 6505-00-139-4600). The requirement consists of one bottle of 0.05 percent, 15 ml solution, to be delivered FOB Destination to the Naval Med Readiness Logistics Cmd in Williamsburg, Virginia, with a required delivery date of October 21, 2026. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. The contract mandates strict adherence to commercial packaging standards, requiring sealed unit containers and exterior shipping containers that protect contents from damage. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation must comply with MIL-STD-2073-1E and special packaging instructions MPWN00001. Additionally, the contractor must comply with FDA regulations, the Buy American and Balance of Payments Program, and specific hazardous material labeling requirements under 29 CFR 1910.1200. Inspection and acceptance will occur at the destination point. Invoicing and payment are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE